Menu

Investors

SEC Filings

SEC Filings

Filing date Form Description View
March 2, 2022 4

Statement of changes in beneficial ownership of securities

View HTML
March 2, 2022 4

Statement of changes in beneficial ownership of securities

View HTML
March 2, 2022 4

Statement of changes in beneficial ownership of securities

View HTML
March 1, 2022 8-K

Report of unscheduled material events or corporate event

EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
March 1, 2022 POSASR

POSASR

View HTML
March 1, 2022 10-K

Annual report which provides a comprehensive overview of the company for the past year

EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
March 1, 2022 POS AM

Post-effective amendment to an S-Type filing

View HTML
February 22, 2022 8-K

Report of unscheduled material events or corporate event

EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
February 18, 2022 4/A

Amendment to a previously filed 4

View HTML
February 10, 2022 SC 13G/A

An amendment to the SC 13G filing

View HTML

Data provided by Kaleidoscope.

Print Page
Email Page
Contact IR
Email Alerts
Tear Sheet

Akebia Therapeutics, Inc.
245 First Street, Suite 1400
Cambridge, MA 02142

Driving Directions

+1 617.871.2098  phone
+1 617.871.2099  fax

Contact Us